NLS Agreement

SAGA Diagnostics has entered into an assay development agreement with AstraZeneca. SAGA Diagnostics will in the course of this agreement develop SAGAsafe dPCR assays towards undisclosed methylated targets for analyses of tissue samples and liquid biopsies. “We have chosen to partner with SAGA because of the ultrasensitive performance of the SAGAsafe technology and possibility to […]

The two companies have announced a collaborative agreement for the development, manufacture, and supply of CT83 (KK-LC-1) mAb. These will be used to develop a diagnostic test to identify tumors that express KK-LC-1. Patients with KK-LC-1 positive tumors may be eligible inclusion in clinical trials of a KK-LC-1 targeted T-Cell therapy, state the companies. “We […]

Salipro Biotech enters into a collaboration and license agreement with AbCellera for access to the Salipro platform for antibody discovery against GPCRs, ion channels, and transporters. The collaboration enables AbCellera to access Salipro Biotech’s expertise and its Salipro platform technology to generate stable antigens for challenging membrane protein drug targets for antibody discovery, the company […]

CombiGene and Spark Therapeutics have announced the signing of an exclusive collaboration and licensing agreement for CombiGene’s CG01 project, a gene therapy which aims to treat drug resistant focal epilepsy. The agreement provides Spark Therapeutics with the exclusive world-wide license to develop, manufacture and commercialize CG01. CombiGene will continue to execute certain aspects of the […]

Xbrane Biopharma and AGC Biologics, a global Biopharmaceutical CDMO, have entered into an agreement to manufacture Xcimzane, a Cimzia biosimilar candidate, for clinical development. Under terms of the agreement, the companies will work together to upscale the established Xcimzane manufacturing process and produce several commercial scale batches for upcoming phase I and phase III clinical […]

Medow has successfully landed its largest sales agreement to date – which is also the largest business deal that a SmiLe company has made during its time in the incubator program. “We are thrilled that we, with help from especially SmiLe and HSN Consultancy, successfully attracted the interest of such a major player outside the […]